Literature DB >> 21710472

Anti-chemokine therapy for the treatment of hepatic fibrosis: an attractive approach.

Grant A Ramm1.   

Abstract

Entities:  

Year:  2011        PMID： 21710472     DOI： 10.1002/hep.24353

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis.

Authors:  Marnie J Wood; Lawrie W Powell; Jeannette L Dixon; V Nathan Subramaniam; Grant A Ramm
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Role of monocyte chemoattractant protein-1 in liver fibrosis with transient myeloproliferative disorder in down syndrome.

Authors:  Kenichiro Kobayashi; Takako Yoshioka; Jun Miyauchi; Atsuko Nakazawa; Nobutaka Kiyokawa; Toshiro Maihara; Ikuya Usami
Journal:  Hepatol Commun       Date:  2018-02-01

3.  Altered pro-inflammatory and anti-inflammatory plasma cytokines levels in children with Down's syndrome: A meta-analysis.

Authors:  Nitu Nigam; Prithvi K Singh; Neena Raizada; Balendra P Singh; Shalini Tripathi; Monica Agrawal; Harish Gupta; Sharad Singh; Ghizal Fatima; Sanjay K Nigam; Shailendra K Saxena
Journal:  J Family Med Prim Care       Date:  2021-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.